Waltham, MA, United States of America

Nasim Kassam

USPTO Granted Patents = 7 


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2001-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Nasim Kassam: Innovator in Antibody Research

Introduction

Nasim Kassam is a prominent inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 7 patents to his name, Kassam's work has advanced therapeutic and diagnostic methods in medicine.

Latest Patents

Kassam's latest patents focus on antibodies that bind to human CXCR3. These patents disclose antibodies and antigen-binding fragments that are specifically designed to target human CXCR3. In preferred embodiments, the antibodies are human. The patents also cover nucleic acids and vectors encoding these antibodies or portions thereof, as well as recombinant cells that contain the nucleic acids. Additionally, the inventions provide compositions comprising the antibodies or antigen-binding fragments. The therapeutic and diagnostic methods that employ these antibodies and fragments are also outlined in his patents.

Career Highlights

Kassam is currently associated with Millennium Pharmaceuticals Limited, where he continues to innovate in the field of antibody research. His work has been instrumental in developing new therapeutic approaches that leverage the unique properties of antibodies.

Collaborations

Some of his notable coworkers include Shixin Qin and Walter Newman. Their collaborative efforts have contributed to the advancement of research in the field.

Conclusion

Nasim Kassam's contributions to antibody research have positioned him as a key figure in biotechnology. His innovative patents and collaborations continue to influence the development of new medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…